DOI 10.1016/bs.ircmb.2026.02.005
IL-23 blockade: A strategy for managing pain-related inflammatory diseases.
Аннотация
IL-23, a cytokine involved in regulating immune system activity, plays an essential role in the development and progression of pain-associated inflammatory disorders. By promoting the differentiation and activation of Th17 cells, IL-23 induces the production of pro-inflammatory cytokines, including IL-17. These pro-inflammatory cytokines are key mediators of tissue damage and chronic inflammation observed in various conditions such as psoriasis, rheumatoid arthritis, and inflammatory bowel disease. This chapter provides a comprehensive overview of the molecular mechanisms underlying IL-23-mediated inflammation and its role in the development of pain. Additionally, the therapeutic potential of IL-23 inhibition is examined, with a particular focus on immunotherapy, through the review of clinical data that supports the high efficacy of IL-23 blockade in reducing inflammation, alleviating symptoms, and improving patient outcomes. Targeting IL-23 is seen as a promising strategy for managing inflammatory diseases, providing an alternative to conventional therapies.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.